IL6 and psoriasis: Inflammatory cytokines, including TNF-α and IL-6, are produced in chronic inflammatory sites, which may migrate into the liver, leading to the production of amyloid A. Recently, a multi-cytokine-targeted drug, JAK inhibitor, has been clinically used in the treatment of psoriasis and atopic dermatitis, with a good response.